Csenge Advisory Group’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-5,510
Closed -$209K 656
2022
Q3
$209K Buy
5,510
+98
+2% +$4.37K 0.02% 551
2022
Q2
$271K Sell
5,412
-2
-0% -$106 0.02% 473
2022
Q1
$278K Buy
+5,414
New +$280K 0.02% 513
2021
Q4
Sell
-5,412
Closed -$259K 606
2021
Q3
$259K Buy
+5,412
New +$275K 0.02% 501
2020
Q3
Sell
-4,804
Closed -$245K 436
2020
Q2
$245K Sell
4,804
-1,797
-27% -$87.3K 0.04% 311
2020
Q1
$289K Buy
6,601
+1,632
+33% +$78.1K 0.08% 219
2019
Q4
$249K Buy
4,969
+54
+1% +$2.53K 0.06% 242
2019
Q3
$228K Buy
+4,915
New +$212K 0.06% 237

Other funds holding SNY

Csenge Advisory Group's SNY Position: Q4 2022 in Review

Csenge Advisory Group sold out of Sanofi (SNY) in Q4 2022, closing a stake of 5,510 shares — an estimated $209K sold.

Csenge Advisory Group first reported a position in SNY in Q3 2019 and held it in 8 quarters. The position peaked at $289K in Q1 2020. 643 funds tracked by Wall St. Rank hold SNY as of Q4 2022.

  • Csenge Advisory Group reported no remaining Sanofi position as of Q4 2022 after selling out during the quarter.
  • Csenge Advisory Group sold 5,510 Sanofi shares in Q4 2022, an estimated $209K.
  • Csenge Advisory Group first reported a position in Sanofi in Q3 2019 and held it in 8 quarters.
  • Csenge Advisory Group's Sanofi position peaked at $289K in Q1 2020.
  • 643 funds tracked by Wall St. Rank held Sanofi as of Q4 2022.

Based on Csenge Advisory Group's 13F filing for Q4 2022, filed 10 Feb 2023.